PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma

BACKGROUND: Leiomyosarcoma (LMS) is a common type of soft tissue sarcoma that responds poorly to standard chemotherapy. Thus the goal of this study was to identify novel selective therapies that may be effective in leiomyosarcoma by screening cell lines with a small molecule library comprised of 480...

Descripción completa

Detalles Bibliográficos
Autores principales: Babichev, Yael, Kabaroff, Leah, Datti, Alessandro, Uehling, David, Isaac, Methvin, Al-awar, Rima, Prakesch, Michael, Sun, Ren X., Boutros, Paul C., Venier, Rosemarie, Dickson, Brendan C., Gladdy, Rebecca A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782390/
https://www.ncbi.nlm.nih.gov/pubmed/26952093
http://dx.doi.org/10.1186/s12967-016-0814-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782390/
https://www.ncbi.nlm.nih.gov/pubmed/26952093
http://dx.doi.org/10.1186/s12967-016-0814-z

Ejemplares similares